CTC
NTUS

Central Trust Company’s Natus Medical Inc NTUS Stock Holding History

Central Trust Company’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-1,203
Closed -$47K – 1321
2017
Q1 		$47K Hold
1,203
– – ﹤0.01% 742
2016
Q4 		$42K Sell
1,203
-161
-12% -$6.32K ﹤0.01% 748
2016
Q3 		$54K Buy
1,364
+50
+4% +$1.99K ﹤0.01% 660
2016
Q2 		$50K Buy
1,314
+72
+6% +$2.41K ﹤0.01% 675
2016
Q1 		$48K Buy
1,242
+315
+34% +$11.7K ﹤0.01% 686
2015
Q4 		$45K Buy
927
+387
+72% +$17.9K ﹤0.01% 673
2015
Q3 		$21K Buy
540
+60
+13% +$2.55K ﹤0.01% 827
2015
Q2 		$20K Hold
480
– – ﹤0.01% 857
2015
Q1 		$19K Hold
480
– – ﹤0.01% 846
2014
Q4 		$17K Buy
+480
New +$16.1K ﹤0.01% 868

Other funds holding NTUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DCM
Daruma Capital Management New York $879M AUM 2.11% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
IAM
Impax Asset Management Portsmouth, New Hampshire $1.69B AUM 16.26% 1-Year Est. Return

Central Trust Company's NTUS Position: Q2 2017 in Review

Central Trust Company sold out of Natus Medical Inc (NTUS) in Q2 2017, closing a stake of 1,203 shares — an estimated $47K sold.

Central Trust Company first reported a position in NTUS in Q4 2014 and held it in 10 quarters. The position peaked at $54K in Q3 2016. 217 funds tracked by Wall St. Rank hold NTUS as of Q2 2017.

  • Central Trust Company reported no remaining Natus Medical Inc position as of Q2 2017 after selling out during the quarter.
  • Central Trust Company sold 1,203 Natus Medical Inc shares in Q2 2017, an estimated $47K.
  • Central Trust Company first reported a position in Natus Medical Inc in Q4 2014 and held it in 10 quarters.
  • Central Trust Company's Natus Medical Inc position peaked at $54K in Q3 2016.
  • 217 funds tracked by Wall St. Rank held Natus Medical Inc as of Q2 2017.

Based on Central Trust Company's 13F filing for Q2 2017, filed 14 Jul 2017.